不同用药方案治疗社区获得性肺炎的疗效及经济学分析  

作　　者：欧晓霞[1] 霍敏琴 

机构地区：[1]佛山市顺德区容桂街道新容奇医院

出　　处：《当代医学》2011年第32期149-150,共2页Contemporary Medicine

摘　　要：目的探讨两种用药方案治疗社区获得性肺炎(CAP)的疗效及经济效果。方法将2009年12月～2010年6月收治的50例CAP患者分为两组,分别采用头孢唑林和阿奇霉素治疗,比较两组的治疗效果并进行药物经济学成本-效果分析。结果头孢唑林组的总有效率为84.0%,阿奇霉素的总有效率为92.0%,两组之间无显著性差异,P>0.05。两种用药方案的成本分别为1016.85元、1057.45元。成本效果比为12.11、11.49,有显著性差异,P<0.05。结论阿奇霉素治疗CAP的方案优于头孢唑林。Objective Discusses two kinds of treatment regimen community-acquired pneumonia （CAP） curative effect and economic effect. Methods Will be our hospital from December 2009 to June 2010 50 patients were divided into two groups, patients with CAP were used respectively to cefazolin and azithromycin treatment, compared with two groups of treatment effect on drugs and economics and cost-effectiveness analysis. Results Cefazolin group of the total effective rate was 84.0%, the azithromycin the total effective rate of 92.0% between the two groups, no significant differences, P〉0.05. Two kinds of drug plan cost 1016.85 yuan respectively, 1057.45 yuan. Cost effect than 12.11, 11.49, there are significant differences, P〈0.05.Conclusion Azithromycin treatment scheme is better than the CAP cefazolin.

关 键 词：社区获得性肺炎 用药方案 疗效 经济学分析 

分 类 号：R563.1[医药卫生—呼吸系统]